NCT04380779View on ClinicalTrials.gov

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

CompletedOBSERVATIONAL
Enrollment

2,430

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
COVID-19
Trial Locations (1)

08916

Manuel Monreal, Badalona

All Listed Sponsors
lead

Manuel Monreal

OTHER

NCT04380779 - Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses | Biotech Hunter | Biotech Hunter